Pharmagreen Biotech Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHBI research report →
About the company
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
- CEO
- Peter Wojcik
- IPO
- 2018
- HQ
- Coquitlam, BC, CA
Price Chart
- Market Cap
- $622.21K
- P/E
- -0.53
- P/S
- 0.14
- P/B
- -0.06
- EV/EBITDA
- -0.52
- Div Yield
- 0.00%
- Gross Margin
- -0.02%
- Op Margin
- -29.70%
- Net Margin
- -28.96%
- ROE
- 21.12%
- ROIC
- 14.07%
- Revenue
- $3.41K · 13.74%
- Net Income
- $-1,004,000 · -76.45%
- EPS
- $-0.00 · -25.00%
- Op Income
- $-248,000
- FCF YoY
- 61.96%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.72
- Avg Volume
- 2.29M
Get TickerSpark's AI analysis on PHBI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PHBI coverage
Recent articles, reports, and earnings notes.
No research on PHBI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHBI report →Similar companies
Peers in the same neighborhood.